Status:
COMPLETED
Neuropsychological Evaluation for Early Diagnosis of PSP
Lead Sponsor:
Ospedale Generale Di Zona Moriggia-Pelascini
Conditions:
Progressive Supranuclear Palsy
Cognitive Impairment
Brief Summary
The aim of this study is to better understand the nature of the cognitive decline in Progressive Supranuclear Palsy, the time of its development and the relation with the other cardinal features of th...
Detailed Description
Progressive Supranuclear Palsy (PSP) is a neurodegenerative disease characterized by vertical supranuclear gaze palsy, early balance dysfunction and falls. Tau-protein aggregation, mainly in the brain...
Eligibility Criteria
Inclusion
- Patients fulfilling the criteria for idiopathic PD
- Patients fulfilling the criteria for PSP
Exclusion
- Any other neurodegenerative disorders or medical conditions different from PD / PSP
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2018
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT03478124
Start Date
January 1 2016
End Date
March 2 2018
Last Update
March 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.